McCullough P A, Ayad O, O'Neill W W, Goldstein J A
Department of Medicine, William Beaumont Hospital, Royal Oak, Michigan, USA.
Clin Cardiol. 1998 Jan;21(1):22-6. doi: 10.1002/clc.4960210105.
Although inroads have been made in the outpatient evaluation of chest pain, the majority of hospitals in the United States do not have chest pain centers and the direct costs associated with hospital admissions in low-risk patients is unknown.
The study was undertaken to evaluate the cost and outcomes of admission to the hospital for patients with acute chest pain and essentially normal electrocardiograms (ECGs).
For that purpose, we reviewed 1,670 patients presenting to our emergency department with chest pain over a 5-month period in 1994. Of these, 567 [34.0%, confidence interval (CI) 95%, 31.7-36.3%] patients were considered to be low risk by ECG criteria alone.
Complete clinical and financial data were available in 445 cases of which 152 had a previous history of coronary artery disease (CAD) and 31 (7.0%, CI 95%, 4.9-9.6%) were ultimately proven to have acute myocardial infarction (AMI). There were no deaths. All patients initially underwent noninvasive evaluation, and an additional 177 (39.8%) underwent subsequent cardiac catheterization. Of those, 107 (60.5%) had significant CAD (at least one vessel > 70% stenosis). We assumed an expected mortality rate of 1% in the AMI group based on previously reported series with all the mortalities preventable by hospitalization. This yielded a valuation of $1.7 million dollars per life saved. Sensitivity analysis revealed the practice of admission and in-patient evaluation for this group of patients was cost ineffective at all assumption levels.
The practice of hospital admission for patients with chest pain and essentially normal ECGs is not cost favorable, and all hospital facilities should consider outpatient chest pain evaluation strategies.
尽管在胸痛的门诊评估方面已取得进展,但美国大多数医院没有胸痛中心,低风险患者住院的直接费用尚不清楚。
本研究旨在评估急性胸痛且心电图基本正常的患者入院的费用和结局。
为此,我们回顾了1994年5个月期间到我院急诊科就诊的1670例胸痛患者。其中,仅根据心电图标准,567例(34.0%,95%置信区间,31.7 - 36.3%)患者被认为是低风险患者。
445例患者有完整的临床和财务数据,其中152例有冠状动脉疾病(CAD)病史,31例(7.0%,95%置信区间,4.9 - 9.6%)最终被证实患有急性心肌梗死(AMI)。无死亡病例。所有患者最初均接受了无创评估,另外177例(39.8%)随后接受了心脏导管检查。其中,107例(60.5%)有显著CAD(至少一支血管狭窄>70%)。根据先前报道的系列研究,我们假设AMI组的预期死亡率为1%,且所有死亡均可通过住院预防。这得出每挽救一条生命的价值为170万美元。敏感性分析显示,对这组患者进行入院和住院评估的做法在所有假设水平上均不具有成本效益。
胸痛且心电图基本正常的患者入院治疗在成本方面并不划算,所有医院机构都应考虑门诊胸痛评估策略。